What's breaking now, across thousands of outlets.
The stock market will soon welcome another drug developer through a backdoor route that has been fallen out of favor now that traditional IPOs are flowing. TriGemX Bio, formerly known as Kallyope, is going public ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The Atlanta Braves lacked a reliable shortstop option as they fell short of their postseason goals again.
“Ill-timed circumstances can change our financial future in unexpected ways.”
“Ill-timed circumstances can change our financial future in unexpected ways.”
Mumbai: L&T Technology Services (LTTS) on Monday reported a consolidated net income of ₹5,482 crore for the second quarter ended September 30, 2026, marking a 66.8% year-on-year increase.
Overnight repos are the most heavily traded product in the interbank money market
Enterprise AI companies relying on armies of forward deployed engineers are disguising labor-intensive services as scalable software, inflating recurring revenue and valuations while falling short of…
